Exosomes on the lookout for lung disease
November, 19 2024
A study in the Journal of Inflammation Research shows how mesenchymal stem cells (MSC) and their exosomes help treat lung diseases: COPD, idiopathic pulmonary fibrosis (IPF), acute respiratory distress syndrome (ARDS), and pneumonia.
MSC secrete bioactive molecules that reduce inflammation and stimulate lung tissue regeneration. Exosomes containing microRNAs and proteins affect key signaling pathways (VEGF/VEGFR2, NF-κB), preventing damage.
A study in the Journal of Inflammation Research shows how mesenchymal stem cells (MSC) and their exosomes help treat lung diseases: COPD, idiopathic pulmonary fibrosis (IPF), acute respiratory distress syndrome (ARDS), and pneumonia.
MSC secrete bioactive molecules that reduce inflammation and stimulate lung tissue regeneration. Exosomes containing microRNAs and proteins affect key signaling pathways (VEGF/VEGFR2, NF-κB), preventing damage.
Latest news
Stem cells: restoring the liver according to science
January, 16 2025
Exosoms: helping blood vessels after treatment
January, 01 2025
Stem cells and exosomes against DIC syndrome
November, 16 2024
How do stem cells help fight kidney aging?
September, 21 2024
Cell therapy options for patients with dystrophic dermatologic epidermolysis bullosa (RDEB)
September, 11 2024